107 related articles for article (PubMed ID: 21810517)
21. Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.
Clarke SJ; Karapetis CS; Gibbs P; Pavlakis N; Desai J; Michael M; Tebbutt NC; Price TJ; Tabernero J
Crit Rev Oncol Hematol; 2013 Feb; 85(2):121-35. PubMed ID: 22762963
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Xu X; Strimpakos AS; Saif MW
JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
[TBL] [Abstract][Full Text] [Related]
23. Novel prognostic biomarkers in colorectal cancer.
Malesci A; Laghi L
Dig Dis; 2012; 30(3):296-303. PubMed ID: 22722555
[TBL] [Abstract][Full Text] [Related]
24. Molecular medicine and the development of cancer chemopreventive agents.
Izzotti A
Ann N Y Acad Sci; 2012 Jul; 1259():26-32. PubMed ID: 22758633
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic biomarkers of colorectal cancer.
Choong MK; Tsafnat G
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):9-15. PubMed ID: 21635968
[TBL] [Abstract][Full Text] [Related]
26. [Recent advancement in biomarkers to predict the clinical outcome for colorectal cancer patients].
Ichikawa W
Nihon Rinsho; 2011 Apr; 69 Suppl 3():220-5. PubMed ID: 22213961
[No Abstract] [Full Text] [Related]
27. Biomarkers and targeted therapeutics in colorectal cancer.
Meguerditchian AN; Bullard Dunn K
Surg Oncol Clin N Am; 2013 Oct; 22(4):841-55. PubMed ID: 24012402
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers for colon diagnosis, prognosis and targeted therapy.
Herzig DO; Tsikitis VL
J Surg Oncol; 2015 Jan; 111(1):96-102. PubMed ID: 25297801
[TBL] [Abstract][Full Text] [Related]
29. Biomarker use in colorectal cancer therapy.
Kelley RK; Wang G; Venook AP
J Natl Compr Canc Netw; 2011 Nov; 9(11):1293-302. PubMed ID: 22056657
[TBL] [Abstract][Full Text] [Related]
30. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges.
Luo Y; Wang L; Wang J
Proteomics Clin Appl; 2013 Jan; 7(1-2):30-41. PubMed ID: 23255431
[TBL] [Abstract][Full Text] [Related]
31. [Are expression signatures worthless?].
Jordan B
Med Sci (Paris); 2012 May; 28(5):547-50. PubMed ID: 22643011
[No Abstract] [Full Text] [Related]
32. Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.
Smits KM; Cleven AH; Weijenberg MP; Hughes LA; Herman JG; de Bruïne AP; van Engeland M
Pharmacogenomics; 2008 Dec; 9(12):1903-16. PubMed ID: 19072647
[TBL] [Abstract][Full Text] [Related]
33. [Response predictive biomarkers to targeted therapies in oncology].
Harlé A; Merlin JL
Ann Biol Clin (Paris); 2013 Nov; 71():89-97. PubMed ID: 24235332
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer stem cells as biomarkers: where it all starts?
Avital I; Summers TA; Steele SR; Waldman S; Nissan A; Bilchik AJ; Protic M; Man YG; Brücher BL; Stojadinovic A
J Surg Oncol; 2013 Jun; 107(8):791-3. PubMed ID: 23512573
[No Abstract] [Full Text] [Related]
35. Clinical relevance of colorectal cancer molecular subtypes.
Rodriguez-Salas N; Dominguez G; Barderas R; Mendiola M; García-Albéniz X; Maurel J; Batlle JF
Crit Rev Oncol Hematol; 2017 Jan; 109():9-19. PubMed ID: 28010901
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic traits as biomarkers in colorectal cancer.
Berg M; Søreide K
Int J Mol Sci; 2011; 12(12):9426-39. PubMed ID: 22272141
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 in colorectal cancer: "Just another brick in the wall"?
Stintzing S; Lenz HJ
J Natl Cancer Inst; 2013 Jun; 105(12):840-1. PubMed ID: 23704279
[No Abstract] [Full Text] [Related]
38. Molecular Taxonomy and Tumourigenesis of Colorectal Cancer.
Biswas S; Holyoake D; Maughan TS
Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):73-82. PubMed ID: 26631427
[TBL] [Abstract][Full Text] [Related]
39. Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.
Fessler E; Medema JP
Trends Cancer; 2016 Sep; 2(9):505-518. PubMed ID: 28741479
[TBL] [Abstract][Full Text] [Related]
40. EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
Sesboüé R; Le Pessot F; Di Fiore F; Frebourg T
Br J Cancer; 2012 Jan; 106(2):426-7; author reply 428. PubMed ID: 22187031
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
